Elevance Health Total Assets 2010-2024 | ELV
Elevance Health total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Elevance Health total assets for the quarter ending December 31, 2024 were $116.889B, a 7.31% increase year-over-year.
- Elevance Health total assets for 2024 were $116.889B, a 7.31% increase from 2023.
- Elevance Health total assets for 2023 were $108.928B, a 6.01% increase from 2022.
- Elevance Health total assets for 2022 were $102.755B, a 5.43% increase from 2021.
| Elevance Health Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $116,889 |
| 2023 | $108,928 |
| 2022 | $102,755 |
| 2021 | $97,460 |
| 2020 | $86,615 |
| 2019 | $77,453 |
| 2018 | $71,571 |
| 2017 | $70,540 |
| 2016 | $65,083 |
| 2015 | $61,718 |
| 2014 | $61,676 |
| 2013 | $59,575 |
| 2012 | $58,955 |
| 2011 | $52,163 |
| 2010 | $50,167 |
| 2009 | $52,125 |
| Elevance Health Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $116,889 |
| 2024-09-30 | $116,533 |
| 2024-06-30 | $112,988 |
| 2024-03-31 | $111,894 |
| 2023-12-31 | $108,928 |
| 2023-09-30 | $110,478 |
| 2023-06-30 | $109,168 |
| 2023-03-31 | $109,040 |
| 2022-12-31 | $102,755 |
| 2022-09-30 | $103,026 |
| 2022-06-30 | $100,877 |
| 2022-03-31 | $100,486 |
| 2021-12-31 | $97,460 |
| 2021-09-30 | $98,060 |
| 2021-06-30 | $96,097 |
| 2021-03-31 | $95,683 |
| 2020-12-31 | $86,615 |
| 2020-09-30 | $86,574 |
| 2020-06-30 | $87,976 |
| 2020-03-31 | $82,399 |
| 2019-12-31 | $77,453 |
| 2019-09-30 | $77,809 |
| 2019-06-30 | $75,851 |
| 2019-03-31 | $74,523 |
| 2018-12-31 | $71,571 |
| 2018-09-30 | $74,445 |
| 2018-06-30 | $74,367 |
| 2018-03-31 | $73,300 |
| 2017-12-31 | $70,540 |
| 2017-09-30 | $68,310 |
| 2017-06-30 | $68,238 |
| 2017-03-31 | $68,944 |
| 2016-12-31 | $65,083 |
| 2016-09-30 | $64,400 |
| 2016-06-30 | $64,063 |
| 2016-03-31 | $63,859 |
| 2015-12-31 | $61,718 |
| 2015-09-30 | $62,336 |
| 2015-06-30 | $64,264 |
| 2015-03-31 | $65,546 |
| 2014-12-31 | $61,676 |
| 2014-09-30 | $62,058 |
| 2014-06-30 | $62,304 |
| 2014-03-31 | $61,686 |
| 2013-12-31 | $59,575 |
| 2013-09-30 | $60,264 |
| 2013-06-30 | $59,612 |
| 2013-03-31 | $59,409 |
| 2012-12-31 | $58,955 |
| 2012-09-30 | $55,818 |
| 2012-06-30 | $54,535 |
| 2012-03-31 | $52,497 |
| 2011-12-31 | $52,163 |
| 2011-09-30 | $52,550 |
| 2011-06-30 | $50,877 |
| 2011-03-31 | $50,918 |
| 2010-12-31 | $50,167 |
| 2010-09-30 | $51,032 |
| 2010-06-30 | $50,160 |
| 2010-03-31 | $51,181 |
| 2009-12-31 | $52,125 |
| 2009-09-30 | $49,498 |
| 2009-06-30 | $49,344 |
| 2009-03-31 | $49,415 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $98.469B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |